chr3-151337857-T-C
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_022788.5(P2RY12):āc.989A>Gā(p.Glu330Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0041 in 1,614,130 control chromosomes in the GnomAD database, including 230 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
NM_022788.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
P2RY12 | NM_022788.5 | c.989A>G | p.Glu330Gly | missense_variant | 3/3 | ENST00000302632.4 | NP_073625.1 | |
MED12L | NM_001393769.1 | c.2251-12202T>C | intron_variant | ENST00000687756.1 | NP_001380698.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
P2RY12 | ENST00000302632.4 | c.989A>G | p.Glu330Gly | missense_variant | 3/3 | 1 | NM_022788.5 | ENSP00000307259.4 | ||
MED12L | ENST00000687756.1 | c.2251-12202T>C | intron_variant | NM_001393769.1 | ENSP00000508695.1 |
Frequencies
GnomAD3 genomes AF: 0.0218 AC: 3313AN: 152222Hom.: 113 Cov.: 32
GnomAD3 exomes AF: 0.00581 AC: 1459AN: 251058Hom.: 55 AF XY: 0.00435 AC XY: 591AN XY: 135730
GnomAD4 exome AF: 0.00225 AC: 3296AN: 1461790Hom.: 117 Cov.: 31 AF XY: 0.00191 AC XY: 1387AN XY: 727186
GnomAD4 genome AF: 0.0218 AC: 3327AN: 152340Hom.: 113 Cov.: 32 AF XY: 0.0208 AC XY: 1551AN XY: 74500
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 22, 2024 | - - |
P2RY12-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 25, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at